Bacterial persistence refers to a state of reduced metabolic activity that endows a subpopulation of isogenic bacteria with multidrug tolerance. Persisters are phenotypic variants but not mutants. Since its discovery in 1944, bacterial persistence has not received enough attention until recently when its implications in persistent infections and biofilm infections become apparent. Much research has been done in recent years to investigate the mechanisms underlying bacterial persistence and phenotypic antibiotic resistance. The mechanisms of bacterial persistence are complex and the following pathways are involved in persister formation: toxin-antitoxin systems, reduced metabolism, energy production, protein and nucleic acid synthesis, DNA repair and protection, protein degradation, transporters/efflux systems, and transcriptional regulators etc. Although persistence mechanisms are conserved in terms of the gene function and pathways involved among different bacterial species, they may vary in gene homology and relative importance of a given pathway. For example, Escherichia coli toxin-antitoxin systems play an important role in persister formation, while Staphylococcus aureus persister formation does not appear to use toxin-antitoxin systems. Here we provide an update on recent progress in persistence mechanisms using E. coli and S. aureus as models, as well as discuss approaches in the treatment of persistent bacterial infections.
Peng Cui, Tao Xu, Wenhong Zhang, Ying Zhang
. Molecular mechanisms of bacterial persistence and phenotypic antibiotic resistance[J]. Hereditas(Beijing), 2016
, 38(10)
: 859
-871
.
DOI: 10.16288/j.yczz.16-213
[1] Balaban NQ. Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev , 2011, 21(6): 768-775.
[2] Zhang Y. Persisters, persistent infections and the Yin-Yang model. Emerg Microbes Infect , 2014, 3(1): e3.
[3] Connolly LE, Edelstein PH, Ramakrishnan L. Why is long-term therapy required to cure tuberculosis? PLoS Med , 2007, 4(3): 435-442.
[4] Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis , 1999, 3(10 Suppl. 2): S231-S279.
[5] Zhang Y, Yew WW, Barer MR. Targeting persisters for tuberculosis control. Antimicrob Agents Chemother , 2012, 56(5): 2223-2230.
[6] Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother , 2010, 54(5): 1855-1863.
[7] Hobby GL, Meyer K, Chaffee E. Observations on the mechanism of action of penicillin. Proc Soc Exp Biol Med , 1942, 50(2): 281-285.
[8] Bigger J. Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet , 1944, 244(6320): 497-500.
[9] Li YF, Zhang Y. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli . Antimicrob Agents Chemother , 2007, 51(6): 2092-2099.
[10] Ma C, Sim S, Shi WL, Du LJ, Xing DM, Zhang Y. Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli . FEMS Microbiol Lett , 2010, 303(1): 33-40.
[11] Allison KR, Brynildsen MP, Collins JJ. Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol , 2011, 14(5): 593-598.
[12] Feng J, Shi WL, Zhang S, Zhang Y. Persister mechanisms in Borrelia burgdorferi : implications for improved intervention. Emerg Microbes Infect , 2015, 4(8): e51.
[13] Moyed HS, Bertrand KP. HipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol , 1983, 155(2): 768-775.
[14] Scherrer R, Moyed HS. Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12. J Bacteriol , 1988, 170(8): 3321-3326.
[15] Black DS, Kelly AJ, Mardis MJ, Moyed HS. Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol , 1991, 173(18): 5732-5739.
[16] Black DS, Irwin B, Moyed HS. Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol , 1994, 176(13): 4081-4091.
[17] Korch SB, Henderson TA, Hill TM. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p) ppGpp synthesis. Mol Microbiol , 2003, 50(4): 1199-1213.
[18] Correia FF, D'Onofrio A, Rejtar T, Li LY, Karger BL, Makarova K, Koonin EV, Lewis K. Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli . J Bacteriol , 2006, 188(24): 8360-8367.
[19] Germain E, Castro-Roa D, Zenkin N, Gerdes K. Molecular mechanism of bacterial persistence by HipA. Mol Cell , 2013, 52(2): 248-254.
[20] Kaspy I, Rotem E, Weiss N, Ronin I, Balaban NQ, Glaser G. HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat Commun , 2013, 4: 3001.
[21] Sekine SI, Nureki O, Dubois DY, Bernier S, Chênevert R, Lapointe J, Vassylyev DG, Yokoyama S. ATP binding by glutamyl-tRNA synthetase is switched to the productive mode by tRNA binding. EMBO J , 2003, 22(3): 676-688.
[22] Shao YC, Harrison EM, Bi DX, Tai C, He XY, Ou HY, Rajakumar K, Deng ZX. TADB: a web-based resource for Type 2 toxin-antitoxin loci in bacteria and archaea. Nucl Acids Res
